Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: larotrectinib | Statement: [Loxo Oncology, developedDrug, larotrectinib]

Target entity: larotrectinib
Context triple: [Loxo Oncology, developedDrug, larotrectinib]

• A. Imfinzi
  Imfinzi is a prescription immunotherapy drug (durvalumab) developed by AstraZeneca, primarily used to treat certain types of lung and bladder cancers by helping the immune system attack cancer cells.
• B. Lynparza
  Lynparza is a targeted cancer therapy (a PARP inhibitor) used primarily to treat certain types of ovarian, breast, pancreatic, and prostate cancers associated with BRCA mutations.
• C. Verzenio
  Verzenio is a prescription cancer medication (abemaciclib) used primarily to treat certain types of hormone receptor–positive, HER2-negative breast cancer.
• D. Inflectra
  Inflectra is a biosimilar monoclonal antibody to infliximab used to treat autoimmune inflammatory conditions such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.
• E. Ibrance
  Ibrance is a targeted oral cancer medication (palbociclib) used primarily to treat certain types of hormone receptor–positive, HER2-negative advanced or metastatic breast cancer.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"

Entity: larotrectinib
Triple: [Loxo Oncology, developedDrug, larotrectinib]

Larotrectinib is a targeted cancer therapy that selectively inhibits TRK fusion proteins and is used to treat solid tumors harboring NTRK gene fusions regardless of tumor site.

Target entity: larotrectinib
Target entity description: Larotrectinib is a targeted cancer therapy that selectively inhibits TRK fusion proteins and is used to treat solid tumors harboring NTRK gene fusions regardless of tumor site.

• A. Imfinzi
  Imfinzi is a prescription immunotherapy drug (durvalumab) developed by AstraZeneca, primarily used to treat certain types of lung and bladder cancers by helping the immune system attack cancer cells.
• B. Lynparza
  Lynparza is a targeted cancer therapy (a PARP inhibitor) used primarily to treat certain types of ovarian, breast, pancreatic, and prostate cancers associated with BRCA mutations.
• C. Verzenio
  Verzenio is a prescription cancer medication (abemaciclib) used primarily to treat certain types of hormone receptor–positive, HER2-negative breast cancer.
• D. Inflectra
  Inflectra is a biosimilar monoclonal antibody to infliximab used to treat autoimmune inflammatory conditions such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.
• E. Ibrance
  Ibrance is a targeted oral cancer medication (palbociclib) used primarily to treat certain types of hormone receptor–positive, HER2-negative advanced or metastatic breast cancer.
• F. None of above. chosen

Target predicate: developedDrug
Context triple: [Loxo Oncology, developedDrug, larotrectinib]

• A. isFirstDrugApprovedFor
  Indicates that a drug is the earliest or original medication approved for treating a particular condition, disease, or indication.
• B. isProdrugOf
  Indicates that one substance is a precursor form that is metabolized in the body to produce the active form of another substance.
• C. developed chosen
  Indicates that one entity created, designed, or brought another entity into a more advanced or complete state through effort or work.
• D. approvedDrugForm
  Indicates that a particular pharmaceutical form (e.g., tablet, injection) is an officially approved formulation of a given drug.
• E. evaluatesDrug
  Indicates that an entity assesses or judges the properties, effectiveness, or impact of a drug.
• F. None of above.